RBF Capital’s Cardlytics CDLX Stock Holding History

RBF Capital’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$359K	Hold	80,010	–	–	0.01%	418
2026 Q1	$840K	Hold	80,010	–	–	0.04%	312
2025 Q4	$920K	Hold	80,010	–	–	0.04%	306
2025 Q3	$1.94M	Sell	80,010 -2,866	-3%	-$47.7K	0.09%	211
2025 Q2	$1.36M	Hold	82,876	–	–	0.06%	254
2025 Q1	$1.51M	Buy	82,876 +2,500	+3%	+$71.4K	0.09%	233
2024 Q4	$2.98M	Buy	80,376 +31,563	+65%	+$1.21M	0.15%	141
2024 Q3	$1.56M	Buy	48,813 +36,962	+312%	+$2.05M	0.08%	235
2024 Q2	$973K	Buy	11,851 +351	+3%	+$38K	0.06%	279
2024 Q1	$1.67M	Buy	+11,500	New	+$971K	0.09%	219

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RBF Capital's CDLX Position: Q2 2026 in Review

RBF Capital held its Cardlytics (CDLX) position steady in Q2 2026 at 80,010 shares worth $359K. The position accounts for 0.01% of the portfolio, ranked #418.

RBF Capital first reported a position in CDLX in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.98M in Q4 2024. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

RBF Capital held 80,010 shares of Cardlytics worth $359K as of Q2 2026.
RBF Capital left its Cardlytics share count unchanged in Q2 2026.
Cardlytics made up 0.01% of RBF Capital's portfolio in Q2 2026, its #418 holding.
RBF Capital first reported a position in Cardlytics in Q1 2024 and has held it in 10 quarters since.
RBF Capital's Cardlytics position peaked at $2.98M in Q4 2024.
42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.